发明名称 |
Method of selecting stem cells having high chondrogenic differentiation capability |
摘要 |
Thrombospondin 1 (TSP-1), TSP-2, interleukin 17B receptor (IL-17BR) and heparin-binding epidermal growth factor-like growth factor (HB-EGF) associated with stem cell activity and use thereof. |
申请公布号 |
US9040298(B2) |
申请公布日期 |
2015.05.26 |
申请号 |
US201012790268 |
申请日期 |
2010.05.28 |
申请人 |
Medipost Co., Ltd. |
发明人 |
Yang Yoon-Sun;Oh Won Il;Jeon Hong Bae;Jung Mee Hyun;Jeong Sang Young |
分类号 |
C12N5/00;A61K38/17;A61K38/18;A61K38/39 |
主分类号 |
C12N5/00 |
代理机构 |
Drinker Biddle & Reath LLP |
代理人 |
Drinker Biddle & Reath LLP |
主权项 |
1. A method of selecting a stem cell capable of differentiating into a chondrocyte or inducing chondrocyte differentiation, the method comprising:
culturing a stem cell in a monolayer or pellet in a maintenance medium; measuring a concentration of TSP-2; and selecting and isolating a stem cell having a high chondrogenic differentiation capability from the culture medium if a) the concentration of TSP-2 in cell culture is larger than 72 pg/ml/1.0×105 cells when the stem cell is monolayer cultured for 1 day, or b) the concentration of TSP-2 in cell culture is larger than 550 pg/ml/1.0×105 cells when the stem cell is pellet cultured for 7 days, wherein the selected stem cell is capable of differentiating into a chondrocyte or inducing chondrocyte differentiation. |
地址 |
Seoul KR |